{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T09:04:26Z","timestamp":1781859866152,"version":"3.54.5"},"reference-count":15,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jogc.2020.06.012","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T21:53:53Z","timestamp":1593640433000},"page":"1475-1482.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Treatment Choices in a National Cohort of Canadian Women With Symptomatic Uterine Fibroids"],"prefix":"10.1016","volume":"42","author":[{"given":"Tim","family":"Strand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Kives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Leyland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ashkenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Janiszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0112-1379","authenticated-orcid":false,"given":"John","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2020.06.012_bib0001","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1701-2163(15)30939-7","article-title":"Abnormal uterine bleeding in pre-menopausal women","volume":"35","author":"Singh","year":"2013","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2020.06.012_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/03007995.2014.982246","article-title":"Contemporary management of uterine fibroids: focus on emerging medical treatments","volume":"31","author":"Singh","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jogc.2020.06.012_bib0003","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1080\/03007995.2017.1372107","article-title":"Impact of uterine fibroid symptoms on health-related quality of life of US women: evidence from a cross-sectional survey","volume":"33","author":"Soliman","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jogc.2020.06.012_bib0004","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6874-12-6","article-title":"Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women","volume":"12","author":"Zimmermann","year":"2012","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.jogc.2020.06.012_bib0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1701-2163(15)30338-8","article-title":"The management of uterine leiomyomas","volume":"37","author":"Vilos","year":"2015","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2020.06.012_bib0006","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1185\/03007995.2015.1107534","article-title":"Burden of symptomatic uterine fibroids in Canadian women: a cohort study","volume":"32","author":"Laberge","year":"2016","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jogc.2020.06.012_bib0007","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/JOM.0000000000001105","article-title":"Examining the relationship between symptomatic burden and self-reported productivity losses among patients with uterine fibroids in the United States","volume":"59","author":"Soliman","year":"2017","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.jogc.2020.06.012_bib0008","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1089\/jwh.2018.7076","article-title":"Burden, prevalence, and treatment of uterine fibroids: asurvey of U.S","volume":"27","author":"Marsh","year":"2018","journal-title":"women. J Womens Health (Larchmt)"},{"key":"10.1016\/j.jogc.2020.06.012_bib0009","doi-asserted-by":"crossref","first-page":"e10926","DOI":"10.2196\/10926","article-title":"A patient registry for the management of uterine fibroids in Canada: protocol for a multicenter, prospective noninterventional study","volume":"7","author":"Bedaiwy","year":"2018","journal-title":"JMIR Res Protoc"},{"issue":"Suppl. 1","key":"10.1016\/j.jogc.2020.06.012_bib0010","first-page":"142A","article-title":"History of pharmacologic and surgical interventions among Canadian women presenting with symptomatic uterine fibroids","volume":"24","author":"Murji","year":"2016","journal-title":"Reprod Sciences"},{"key":"10.1016\/j.jogc.2020.06.012_bib0011","unstructured":"EQ-5D. EQ-5D-5L. Available at:https:\/\/euroqol.org\/eq-5d-instruments\/eq-5d-5l-about\/. Accessed December 15, 2018."},{"key":"10.1016\/j.jogc.2020.06.012_bib0012","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jval.2011.07.007","article-title":"Further validation of the uterine fibroid symptom and quality-of-life questionnaire","volume":"15","author":"Coyne","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.jogc.2020.06.012_bib0013","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/03007995.2016.1248382","article-title":"Validation of the 4 week recall version of the Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) Questionnaire","volume":"33","author":"Coyne","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jogc.2020.06.012_bib0014","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1089\/jwh.2015.5531","article-title":"An altered perception of normal: understanding causes for treatment delay in women with symptomatic uterine fibroids","volume":"25","author":"Ghant","year":"2016","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.jogc.2020.06.012_bib0015","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/AOG.0000000000002331","article-title":"Comparative effectiveness of uterine leiomyoma procedures using a large insurance claims database","volume":"130","author":"Borah","year":"2017","journal-title":"Obstet Gynecol"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216320305284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216320305284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:37:08Z","timestamp":1761665828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216320305284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1701216320305284"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2020.06.012","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment Choices in a National Cohort of Canadian Women With Symptomatic Uterine Fibroids","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2020.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}